Product Program year 2021 Source: CMS Open Payments

Cobalt

Device Implantable Cardioverter Defibrillators (ICDs)

PDI 00763000178390

Open in the dashboard

General payments

$136,733

3,872 payments

Research payments

$3,714,830

1,439 payments

Through program year 2021, $136,733 in general payments and $3,714,830 in research payments were reported against Cobalt (Implantable Cardioverter Defibrillators (ICDs)).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2021 General $136,733 3,872
2021 Research $3,714,830 1,439

Breakdown

Who paid General payments · program year 2021
  1. Medtronic, Inc. $136,733 3,872 payments
Top recipients General payments · program year 2021
  1. Daejoon Anh Clinical Cardiac Electrophysiology · Henderson, NV $1,308 <1% · 17 payments
  2. Sameer Parekh Clinical Cardiac Electrophysiology · Garden City, NY $886 <1% · 30 payments
  3. Christine King Physician Assistant · Mineola, NY $791 <1% · 30 payments
  4. Monica Oliveira Physician Assistant · Mineola, NY $678 <1% · 25 payments
  5. Joseph Germano Clinical Cardiac Electrophysiology · Mineola, NY $658 <1% · 32 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Clinical Cardiac Electrophysiology Internal Medicine $57,679 43% · 599 practitioners
  2. Cardiovascular Disease Internal Medicine $31,694 23% · 469 practitioners
  3. Interventional Cardiology Internal Medicine $12,555 9% · 176 practitioners
  4. Physician Assistant $6,428 5% · 78 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $4,652 3% · 84 practitioners

The top 5 of 51 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. New York $19,366 14% · 178 recipients
  2. Florida $19,239 14% · 221 recipients
  3. Texas $13,031 10% · 164 recipients
  4. California $12,273 9% · 180 recipients
  5. Puerto Rico $10,696 8% · 85 recipients

The top 5 of 48 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

3,872 general · 1,439 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record